EverSource Wealth Advisors’s CONMED CNMD Stock Holding History

EverSource Wealth Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2K	Buy	435 +205	+89%	+$7.38K	﹤0.01%	2681
2026 Q1	$8.13K	Sell	230 -39	-14%	-$1.59K	﹤0.01%	3025
2025 Q4	$10.9K	Buy	269 +201	+296%	+$8.74K	﹤0.01%	2752
2025 Q3	$3.2K	Sell	68 -153	-69%	-$7.93K	﹤0.01%	3341
2025 Q2	$11.5K	Buy	221 +138	+166%	+$7.57K	﹤0.01%	2715
2025 Q1	$5.01K	Buy	83 +43	+108%	+$2.77K	﹤0.01%	2492
2024 Q4	$2.74K	Buy	40 +12	+43%	+$836	﹤0.01%	2592
2024 Q3	$2.01K	Sell	28 -5	-15%	-$353	﹤0.01%	2547
2024 Q2	$2.28K	Sell	33 -41	-55%	-$2.99K	﹤0.01%	2507
2024 Q1	$5.03K	Buy	74 +24	+48%	+$2.14K	﹤0.01%	2051
2023 Q4	$5.48K	Buy	+50	New	+$5.17K	﹤0.01%	1821
2023 Q3	–	Sell	-4	Closed	-$544	–	2532
2023 Q2	$544	Buy	+4	New	+$488	﹤0.01%	2336
2022 Q4	–	Sell	-26	Closed	-$2K	–	2328
2022 Q3	$2K	Sell	26 -2	-7%	-$189	﹤0.01%	1640
2022 Q2	$3K	Sell	28 -127	-82%	-$15.2K	﹤0.01%	1386
2022 Q1	$23K	Hold	155	–	–	0.01%	642
2021 Q4	$22K	Buy	+155	New	+$22K	0.01%	636

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

EverSource Wealth Advisors's CNMD Position: Q2 2026 in Review

EverSource Wealth Advisors increased its CONMED (CNMD) stake by 89% in Q2 2026, buying an estimated $7.38K and bringing the position to 435 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

EverSource Wealth Advisors first reported a position in CNMD in Q4 2021 and has held it in 16 quarters since. The position peaked at $23K in Q1 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

EverSource Wealth Advisors held 435 shares of CONMED worth $14.2K as of Q2 2026.
EverSource Wealth Advisors bought 205 CONMED shares in Q2 2026, an estimated $7.38K.
CONMED made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2681 holding.
EverSource Wealth Advisors first reported a position in CONMED in Q4 2021 and has held it in 16 quarters since.
EverSource Wealth Advisors's CONMED position peaked at $23K in Q1 2022.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.